Viewing Study NCT00458302

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2026-02-23 @ 8:06 PM
Study NCT ID: NCT00458302
Status: COMPLETED
Last Update Posted: 2012-12-19
First Post: 2007-04-06
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Sponsor: Janssen-Cilag International NV
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None AIDS Virus View
None Human Immunodeficiency Virus View
None Acquired Immunodeficiency Syndrome Virus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV View
None Monotherapy View
None Darunavir View
None Protease inhibitor View
None Early pre-treated View
None Undetectable View
None Treatment Experienced View